
Align Technology (ALGN) Stock Forecast & Price Target
Align Technology (ALGN) Analyst Ratings
Bulls say
Align Technology demonstrates a robust financial position, with 2022 reporting over 2 million new Invisalign cases treated, indicating a 4.9% year-over-year growth in case starts to 647.8k in the most recent quarter. The company showcased strong regional performance, particularly in Asia-Pacific and EMEA markets, contributing to a favorable geographic mix and a projected sequential revenue increase of 4% into the fourth quarter. Additionally, Align Technology's significant investment in digital scanning technology, with over 85% of Invisalign cases initiated through digital scans from their iTero brand, positions the company for continued market leadership and operational efficiency.
Bears say
Align Technology's stock faces a negative outlook primarily due to challenges in revenue visibility, exacerbated by disappointing average selling price (ASP) trends and a slower-than-expected ramp-up in revenue for the fourth quarter. The ASP for clear aligners has declined for seven consecutive quarters, affected by the faster growth in lower ASP markets, leading to a reported year-over-year decrease of 3.9%. Additionally, competition and potential economic pressures on patient demand further contribute to concerns about the company's market position and financial performance moving forward.
This aggregate rating is based on analysts' research of Align Technology and is not a guaranteed prediction by Public.com or investment advice.
Align Technology (ALGN) Analyst Forecast & Price Prediction
Start investing in Align Technology (ALGN)
Order type
Buy in
Order amount
Est. shares
0 shares